Pesquisar
Johnson & Johnson
JNJAdicionar à lista de desejos
275.230USD
-3.200-1.15%
Fechamento 09-04 16:00（ET）
662.84BValor de mercado
31.50P/L TTM
Mais detalhes de Johnson & Johnson Empresa
Johnson & Johnson and its subsidiaries are engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company’s segments include Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, cardiovascular and metabolism. Its products include REMICADE (infliximab), SIMPONI (golimumab), SIMPONI ARIA (golimumab), STELARA (ustekinumab), TREMFYA (guselkumab), EDURANT (rilpivirine), and INVEGA SUSTENNA/XEPLION (paliperidone palmitate). The MedTech segment includes a portfolio of products used in cardiovascular, orthopedics, surgery, and vision categories. The Cardiovascular portfolio includes electrophysiology products to treat heart rhythm disorders and circulatory restoration products (Shockwave) for the treatment of calcified coronary artery disease (CAD) and peripheral artery disease (PAD).
Johnson & Johnson Perfil
Código da empresaJNJ
Nome da EmpresaJohnson & Johnson
Data de listagemOct 31, 2080
CEODuato (Joaquin Boix)
Número de funcionários138100
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 31
EndereçoOne Johnson & Johnson Plaza
CidadeNEW BRUNSWICK
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal08933
Telefone17325242455
Sitehttps://www.jnj.com/
Código da empresaJNJ
Data de listagemOct 31, 2080
CEODuato (Joaquin Boix)
Executivos da empresa Johnson & Johnson
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joaquin Boix Duato
Mr. Joaquin Boix Duato
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
307.82K
-15.75%
Mr. Joaquin Boix Duato
Mr. Joaquin Boix Duato
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
307.82K
-15.75%
Mr. Joaquin Boix Duato
Mr. Joaquin Boix Duato
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
307.82K
-15.75%
Ms. Jennifer L. Taubert
Ms. Jennifer L. Taubert
Executive Vice President, Worldwide Chairman, Innovative Medicine
Executive Vice President, Worldwide Chairman, Innovative Medicine
194.45K
--
Ms. Kathryn E. Wengel
Ms. Kathryn E. Wengel
Executive Vice President, Chief Technical Operations & Risk Officer
Executive Vice President, Chief Technical Operations & Risk Officer
114.63K
--
Ms. Kathryn E. Wengel
Ms. Kathryn E. Wengel
Executive Vice President, Chief Technical Operations & Risk Officer
Executive Vice President, Chief Technical Operations & Risk Officer
114.63K
--
Ms. Kathryn E. Wengel
Ms. Kathryn E. Wengel
Executive Vice President, Chief Technical Operations & Risk Officer
Executive Vice President, Chief Technical Operations & Risk Officer
114.63K
--
Mr. Joseph J. Wolk
Mr. Joseph J. Wolk
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
85.01K
+0.07%
Mr. Joseph J. Wolk
Mr. Joseph J. Wolk
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
85.01K
+0.07%
Mr. Joseph J. Wolk
Mr. Joseph J. Wolk
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
85.01K
+0.07%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joaquin Boix Duato
Mr. Joaquin Boix Duato
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
307.82K
-15.75%
Mr. Joaquin Boix Duato
Mr. Joaquin Boix Duato
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
307.82K
-15.75%
Mr. Joaquin Boix Duato
Mr. Joaquin Boix Duato
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
307.82K
-15.75%
Ms. Jennifer L. Taubert
Ms. Jennifer L. Taubert
Executive Vice President, Worldwide Chairman, Innovative Medicine
Executive Vice President, Worldwide Chairman, Innovative Medicine
194.45K
--
Ms. Kathryn E. Wengel
Ms. Kathryn E. Wengel
Executive Vice President, Chief Technical Operations & Risk Officer
Executive Vice President, Chief Technical Operations & Risk Officer
114.63K
--
Ms. Kathryn E. Wengel
Ms. Kathryn E. Wengel
Executive Vice President, Chief Technical Operations & Risk Officer
Executive Vice President, Chief Technical Operations & Risk Officer
114.63K
--
Perguntas frequentes
Quem são os cinco principais acionistas de Johnson & Johnson?
Os cinco principais acionistas de Johnson & Johnson são: Mr. Joaquin Boix Duato
Quantas instituições possuem ações da Johnson & Johnson (JNJ)?
Em 2026Q1, 6338 instituições possuíam ações da Johnson & Johnson, com valor de mercado aproximado de 1.78B, representando 73.80% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -65473493.00.